Medicare Enrolled
Dr. Maithili Rao, M.D.
Hematology & Oncology · Springfield, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rao
Dr. Maithili Rao is a hematology & oncology specialist in Springfield, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 1,695 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rao received a total of $49,507 from 74 pharmaceutical and/or device companies across 490 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 1,695 Medicare services
$49,507 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,695
Medicare services
Bottom 48% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
595 | $73 | $247 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $108 | $363 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
307 | $146 | $487 |
| New patient office visit, complex (60-74 min) | 92 | $184 | $691 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
91 | $147 | $733 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
82 | $68 | $240 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
56 | $1 | $10 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $102 | $343 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
46 | $13 | $72 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
14 | $92 | $369 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$49,507
Total received (2018-2024)
Avg $7,072/year across 7 years
Top 5% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
490
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$995
2023
$1,222
2022
$779
2021
$527
2020
$10,480
2019
$13,962
2018
$21,541
Payments by company (2024)
Pharmacosmos Therapeutics Inc.
$123
GlaxoSmithKline, LLC.
$116
PFIZER INC.
$113
Novartis Pharmaceuticals Corporation
$70
ABBVIE INC.
$48
E.R. Squibb & Sons, L.L.C.
$40
Genentech USA, Inc.
$35
Merck Sharp & Dohme LLC
$34
Celgene Corporation
$32
Lilly USA, LLC
$21
SpringWorks Therapeutics, Inc.
$21
BeiGene USA, Inc.
$21
Mirati Therapeutics, Inc.
$20
ADC Therapeutics America, Inc.
$20
Eisai Inc.
$20
Gilead Sciences, Inc.
$19
Blueprint Medicines Corporation
$19
Tempus AI, Inc
$19
Daiichi Sankyo Inc.
$19
Exelixis Inc.
$19
Regeneron Healthcare Solutions, Inc.
$19
Incyte Corporation
$18
Deciphera Pharmaceuticals Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Genmab U.S., Inc.
$17
EMD Serono, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
TAIHO ONCOLOGY, INC.
$16
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$39,160
Janssen Pharmaceuticals, Inc
$3,812
Novartis Pharmaceuticals Corporation
$856
Janssen Biotech, Inc.
$594
PFIZER INC.
$462
E.R. Squibb & Sons, L.L.C.
$331
Lilly USA, LLC
$278
GlaxoSmithKline, LLC.
$256
Gilead Sciences, Inc.
$250
Genentech USA, Inc.
$237
Merck Sharp & Dohme Corporation
$192
AstraZeneca Pharmaceuticals LP
$149
Pharmacosmos Therapeutics Inc.
$140
Astellas Pharma US Inc
$133
Amgen Inc.
$131
Puma Biotechnology, Inc.
$125
Merck Sharp & Dohme LLC
$118
Blueprint Medicines Corporation
$105
Janssen Products, LP
$100
Mirati Therapeutics, Inc.
$95
Sirtex Medical Inc
$95
Daiichi Sankyo Inc.
$92
AVEO Pharmaceuticals, Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$67
Foundation Medicine, Inc.
$67
GENZYME CORPORATION
$64
Eisai Inc.
$64
ABBVIE INC.
$63
PORTOLA PHARMACEUTICALS, INC.
$59
Pharmacyclics LLC, An AbbVie Company
$56
Celgene Corporation
$56
Kite Pharma, Inc.
$55
AMAG Pharmaceuticals, Inc.
$55
BeiGene USA, Inc.
$52
Bayer HealthCare Pharmaceuticals Inc.
$50
Myriad Genetic Laboratories, Inc.
$49
Exelixis Inc.
$45
Genmab U.S., Inc.
$45
Alexion Pharmaceuticals, Inc.
$44
Kyowa Kirin, Inc.
$41
AbbVie, Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
MEDIVATION FIELD SOLUTIONS LLC
$39
Medtronic USA, Inc.
$36
Rigel Pharmaceuticals, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$34
EMD Serono, Inc.
$32
Janssen Scientific Affairs, LLC
$31
Partner Therapeutics, Inc.
$31
CTI BioPharma Corp.
$29
AbbVie Inc.
$29
ImmunoGen, Inc.
$29
Seattle Genetics, Inc.
$25
SpringWorks Therapeutics, Inc.
$21
Adaptive Biotechnologies Corporation
$21
Stemline Therapeutics Inc.
$20
ADC Therapeutics America, Inc.
$20
Tempus AI, Inc
$19
MACROGENICS, INC.
$19
Deciphera Pharmaceuticals Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Clovis Oncology, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
MorphoSys, US Inc.
$16
TAIHO ONCOLOGY, INC.
$16
Epizyme, Inc.,
$15
Welch Allyn
$15
Seagen Inc.
$14
TESARO, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$14
Acceleron Pharma, Inc.
$13
Pharmacyclics LLC, an AbbVie Company
$13
Baxter Healthcare
$13
Top 3 companies account for 88.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · ANDEXXA · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BEVYXXA · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Creon · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · ERLEADA · Elahere · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GAVRETO · GAZYVA · GILOTRIF · Herceptin · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · None · Nplate · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · Perjeta · Polivy · QINLOCK · REBLOZYL · RYDAPT · Reblozyl · Rezlidhia · Rubraca · SANDOSTATIN · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tivdak · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
602
County median income
$100,117
Nearest hospital to ZIP centroid (approximate)
OVERLOOK MEDICAL CENTER
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rao is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rao experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rao performed 595 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $49,507 from 74 companies across 490 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other hematology & oncology specialists in Springfield?
Dr. Rao's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Springfield
Browse hematology & oncology specialists in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology